!!Anna Dominiczak - Curriculum Vitae \\ __Current Post:__ Regius Chair of Medicine, University of Glasgow; Director of Laboratories and SRO, Rosalind Franklin Laboratory, NHS Test & Trace, Department of Health & Social Care, UK Government; Honorary Consultant Physician and Endocrinologist, Greater Glasgow and Clyde Health Board; and Health Innovation Champion for the Medical Research Council\\ \\ Researcher ID: P-9390-2017 Orcid ID: 0000-0003-4913-3608\\ \\ __Degrees & Honours:__ \\ *1978 MD Honours, Medical School, Gdansk, Poland\\ *1986 MRCP (UK)\\ *1989 MD University of Glasgow - Thesis: “Platelet cytosolic free calcium and echocardiographic ventricular mass in essential hypertension and left primary hyperparathyroidism” \\ *1995 FRCP (Glasgow, London, Edinburgh) *2005 O.B.E. for services to medicine *2016 D.B.E. for services to cardiovascular and medical sciences *2016 Honorary Degree, Doctor of Science, Glasgow Caledonian University *2018 Honorary Degree, Doctor of Science, University of Aberdeen \\ __Academic Distinctions and Awards:__ \\ *International Fellowship of the American Heart Association (F.A.H.A.) 1996\\ *FMedSci (Fellowship of the Academy of Medical Sciences) 2001\\ *FRSE (Fellowship of the Royal Society of Edinburgh) 2003\\ *The Lecturer of the Year, Belgian Hypertension Society 2003\\ *Presidential Award and Lecture, Canadian Hypertension Society 2003\\ *Arthur Corcoran Award and Lecture, American Heart Association 2004\\ *RD Wright Award and Lecture, High Blood Pressure Research, Council of Australia 2005\\ *The Lord Provost’s Special Award for contribution and commitment to the Health of Glasgow 2007\\ *Scotswoman of the Year 2007\\ *Bjorn Folkow Award and Lecture, European Society of Hypertension 2008\\ *Fellowship of the European Society of Cardiology 2008\\ *The Graham Lecture and Medal, The Royal Philosophical Society of Glasgow 2009\\ *Sackler Fellowship and Lecture, Tel Aviv 2010\\ *Fellowship of the Society of Biology 2010\\ *The William Harvey Outstanding Contribution to Science Award and Lecture, London 2013\\ *The Robert Tigerstedt Award and Lecture, Helsinki 2014\\ *Visiting Professorship, Sun Yat Sen University, Guangzhou, China 2015\\ *Visiting Professorship, Chinese University of Hong Kong 2016\\ *The Pickering Lecture, British and Irish Hypertension Society 2017\\ *Sir Derrick Melville Dunlop Lecture, Royal College of Physicians, Edinburgh 2018\\ *Fitzgerald Peel Lecture, Scottish Society of Physicians 2019\\ *Advisory Professor of Shanghai Jiao Tong University School of Medicine 2019\\ *Distinguished Achievement Award at Hypertension 2020 Scientific Sessions 2020\\ *Fellowship of the Association of Physicians of Great Britain & Ireland 2021 \\ __Posts Held:__ \\ *Director of Laboratories, NHS Test & Trace, Department of Health & Social Care, UK Government 2020 \\ *Health Innovation Champion, Medical Research Council 2019 \\ *Vice Principal and Head of College of Medical, Veterinary and Life Sciences 2010 - 2020\\ *Head of Division of Cardiovascular and Medical Sciences 2008 - 2010\\ *Associate Dean for Research, Faculty of Medicine 2003 - 2010\\ *Director, BHF Glasgow Cardiovascular Research Centre 2001 - 2010\\ *BHF Professor of Cardiovascular Medicine 1998 - 2010\\ *1997 Professor of Cardiovascular Medicine, Personal Chair, University of Glasgow \\ *Senior Lecturer and Reader in Medicine and Honorary Consultant 1993 - 1996\\ *Physician and Endocrinologist, University of Glasgow \\ *British Heart Foundation Senior Research Fellow 1993 - 1998\\ *Clinical Lecturer and Honorary Senior Registrar in Medicine and Endocrinology, 1992 - 1993\\ *Department of Medicine and Therapeutics, University of Glasgow \\ __Membership of Professional Societies:__ \\ *British Medical Association 1983\\ *Scottish Society of Experimental Medicine 1988 \\ *British Hypertension Society 1989 - \\ *International Society of Hypertension 1991\\ *European Society of Hypertension 1992\\ *Caledonian Society for Endocrinology 1992\\ *British Endocrine Society 1994 \\ *Scottish Society of Physicians 1995 \\ *Association of Physicians of Great Britain and Ireland 1997 \\ *American Physiological Society 1998 \\ *British Atherosclerosis Society 2003\\ *Honorary Life Member, High Blood Pressure Research Council of Australia 2005\\ *Honorary Life Member, Polish Hypertension Society 2005 \\ *British Cardiovascular Society 2006 \\ *European Atherosclerosis Society 2012 \\ __Executive Roles in Professional Societies:__ \\ *Scottish Society of Experimental Medicine - Council Member 1992 - 2001, Secretary 1998 - 2001\\ *International Society of Hypertension - Member of the Scientific Council 1998 - 2000, Member at Large of Scientific Council 2000 - 2002, Secretary of the Society 2002 - 2006\\ *British Hypertension Society - Member of the Executive Committee 1999 - 2002\\ *European Society of Hypertension - Member of the Scientific Council 2002 - 2009, Member at Large of Scientific Council 2009 - 2011, Vice President of Scientific Council 2011 - 2013, President of the ESH 2013 - 2015\\ *American Heart Association - Member, Publication Committee 2002 - 2007, Member, Membership Committee 2003 - 2008, Member, International Membership Task Force 2005 - 2007, Member, Awards Committee 2007 - 2010, Member, Leadership Committee 2010 \\ *Association of Physicians of Great Britain - President Elect & President 2018 - 2021 and Ireland\\ *National/International Research Committees & Advisory Boards\\ *Member, Chief Scientist Office Advisory Group on Cardiovascular Disease and Stroke 2002 - 2007\\ *Member, Royal Society of Edinburgh, International Committee 2004 - 2008\\ *Member, Royal Society of Edinburgh, Research Fellowship Committee 2005 - 2007\\ *Chair, Royal Society of Edinburgh, Sectional Committee 2007 - 2009\\ *Member, Council, Royal Society of Edinburgh 2009 - 2015\\ *Member, Research Assessment Exercise 2008, Cardiovascular Sub-panel 2005 - 2008\\ *Member, Wellcome Trust Physiological Sciences Funding Committee 2005 - 2008\\ *Member, Foundation Leducq, Scientific Advisory Committee (Vice President 2009-2011) 2006 - 2011\\ *Member, Max-Delbrück Centre for Molecular Medicine (MDC) Scientific Advisory Board 2007 - 2016 \\ *Member, George Pompidou European Hospital (HEGP) Paris Scientific Advisory Board 2007 \\ *Member, MRC Clinical Training & Career Development Panel 2010 - 2012\\ *Member, Medical Schools Council 2010 - 2020\\ *Member, Board for Academic Medicine (Scotland) 2010 - 2020\\ *Member, Health Committee, Universities Scotland 2011 - 2013\\ *Member, Health Science Scotland Oversight Board 2011 - 2018\\ *Member, Council of the Academy of Medical Sciences 2012 - 2014\\ *Vice President, Life Sciences, Royal Society of Edinburgh 2012 - 2015\\ *Member, Research Excellence Framework, Clinical Medicine Panel 2013 - 2014\\ *Member, MRC Stratified Medicine Panel 2013 - 2018\\ *Trustee, British Heart Foundation, Board of Trustees 2014 - 2020\\ *Chair, MRC Translational Research Group 2016\\ *Member, MRC Strategy Board 2016\\ *Member, Medical Schools Council Executive 2016 - 2020\\ *Chair, Equality & Diversity Working Group, Medical, Dental & Veterinary School Councils 2016 - 2018\\ *Member, Research Excellence Framework Main Panel A (interdisciplinary role) 2018 - 2021\\ *Member of the Council, Academy of Medical Sciences 2018\\ *Member of the Scottish Science Advisory Committee 2018\\ *Scientific Advisory Board, Monash University, Australia 2018 \\ *Member, Health and Social Care Innovation Steering Group 2020 - 2023\\ *National Institute of Health Research / NHS England/Improvement – 2020\\ *Academic Health Science Centre Competition\\ *Chair, International Scientific Council at the Medical University of Gdansk 2020\\ *Chair, UKRI Living Laboratory Programme Scientific Steering Group 2020\\ *Member, UKRI Living Laboratory (SIPF) Governance Committee 2020 \\ *Academy of Medical Sciences, Academy’s FORUM Advisory Group 2021 \\ *NIHR Biomedical Research Centre International Selection Committee 2021 - 2022\\ *Chair, Pharmacogenomics Informed Medication Management Project Programme Board 2021 \\ __Editorial Work:__ \\ *Editor in Chief - Hypertension (Journal of the American Heart Association) 2012 - 2022\\ *Consulting Editor - Hypertension Research 2012 \\ *Associate Editor - Journal of Hypertension 2009 - 2012\\ *Editor in Chief - Clinical Science 2004 - 2008 \\ __Editorial Board Member:__ \\ *Journal of Hypertension 1994\\ *Hypertension 1998 \\ *Physiological Genomics 1999 \\ *Blood Pressure 2001\\ *Cell Metabolism 2004 \\ *Current Hypertension Reviews 2004 \\ *American Journal of Hypertension 2006\\ *Internal and Emergency Medicine 2006\\ *Journal of the American Society of Hypertension 2006 \\ *The Asia-Pacific Journal of General Practice 2009 \\ *Global Heart 2011 \\ *Arterial Hypertension 2015 \\ __Major Research Grants and Infrastructure Awards:__ \\ *British Heart Foundation Tenure Amount\\ *4 x BHF Programme Grants 1999 - 2014 £4,098,853\\ *3 x BHF Infrastructure Awards 2000-2009 £7,469,790\\ *BHF 4 Year PhD Programme 2009 - 2016 £1,971,768\\ *Medical Research Council\\ *The MRC British genetics of hypertension (BRIGHT) study: 2003 - 2008 £1,917,104, grant number G9521010 (with Profs Caulfield, Benjamin, Brown, Clayton, Connell, Dominiczak, Lathrop, and Samani and Drs Farrall, Munroe and Webster).\\ *United Kingdom collaborative study to identify major genes 1996 - 2003 £2,156,734 responsible for human essential hypertension. Programme Grant with representatives of 4 other major centres within the UK. \\ *United Kingdom collaborative study - establishment of a 1999 - 2003 £770,193 transmission disequilibrium testing resource for fine mapping within the MRC British Genetics of Hypertension (with Prof Mark Caulfield & representatives of 4 other major centres within the UK).\\ *University of Glasgow Confidence in Concept 2013 2014 - 2015 £500,000\\ *Imaging Centre of Excellence 2015 - 2017 £16,000,000\\ *Glasgow Molecular Pathology (GMP) Node 2015 - 2018 £3,429,806\\ *Priming Innovative Translational Research - The Glasgow 2016-2017 £500,000\\ *Chemical Biology Programme\\ *Accelerating Precision Diagnostics - Bridging the Gap 2017 - 2019 £280,000\\ *Capital Award - Contribution to Institute of Health & Wellbeing building 2017 - 2019 £7,500,000\\ *Glasgow Precision Diagnostics & Therapeutics - Confidence in Concept 2018 - 2020 £413,000\\ *University of Glasgow Confidence in Concept 2019 & 2020 2019 - 2022 £898,200\\ *UKRI Strength in Places Fund - The Living Laboratory 2020 - 2025 £91,000,000\\ *(£38m + matched funding from consortium partners of £53m)\\ *Wellcome Trust \\ *Cardiovascular Functional Genomics: translating experimental work to 2002 - 2009 £5,300,000 human disease (with Prof N Samani & representatives of 3 other centres).\\ *WTCCC3 core activities (with Prof Leena Peltonen, Dr Linda Morgan 2009 - 2011 £4,513,859 & other consortium members).\\ *Institutional Strategic Support Fund (ISSF1, ISSF2, ISSF3) 2011 - 2019 £7,500,000\\ *Glasgow CRF: translating research into benefits for patients 2015 £750,000\\ *2 x Institutional Translational Partnership Awards 2019 - 2022 £1,400,000\\ *Institutional Strategic Support Fund 2019 - 2021 £1,500,000\\ *The Wolfson Foundation\\ *Glasgow Clinical Research Facility 2012 - 2013 £850,000\\ *The Dr Mortimer and Theresa Sackler Foundation\\ *Glasgow Clinical Research Facility and Imaging Research Facility 2014 - 2016 £3,500,000\\ *Scottish Funding Council \\ *University of Glasgow component (joint with Dr D Blackbourn) of 2001 - 2003 £335,000\\ *£2.2M to establish Scottish Centre for Genomic Microarray Technology \\ *Genetic Health in the 21st Century Project. 2004 - 2007 £247,268 \\ *Biomarkers for battling chronic diseases 2007 - 2012 £1,211,355 (with Profs W Kolch, D Porteous, A Morris and B. Smith).\\ *Stratified Medicine Scotland Innovation Centre. 2012 - 2017 £8,000,000\\ *Additional funding to support location of Stratified Medicine Scotland 2012 - 2013 £5,000,000\\ *Innovation Centre at Queen Elizabeth University Hospital, Glasgow.\\ *Leader Skills Development 2018 - 2019 £107,239\\ *SMS-IC Maintenance Contract 2019 - 2020 £413,772\\ *Scottish Executive Health Department\\ *Scottish Ecosystem for Precision Medicine 2016 - 2017 £4,000,000\\ *Scottish Enterprise\\ *Stratified Medicine Scotland Innovation Centre (phase 2) 2019 - 2024 £2,000,000\\ *Chief Scientist Office \\ *Generation Scotland-Genetics and Healthcare Initiative 2005 - 2009 £4,300,000 Total (with Prof A Morris, Prof D Porteous and Dr B Smith) £1,355,306 Glasgow\\ *Generation Scotland - continuation of Genetics and 2008 - 2011 £3,870,000 Total\\ *Healthcare Initiative (same co-PIs as above). £1,049,157 Glasgow\\ *The Precision Medicine Ecosystem. 2016-2017 £3,480,000\\ *Hypertension, inhibitors of the renin angiotensin system and COVID-19 2020 £76,846\\ *Science Research Investment Fund 2 (SRIF2) Programme\\ *Funding for GCRC/GBRC Research Centres (with Profs Liew & Kolch) 2004 - 2006 £1,200,000\\ *UK Government Department of Health & Social Care\\ *The Lighthouse Laboratory 2020 £16,974,229\\ *Eluceda\\ *Validation-diagnostic COVID-19 test Eluceda 2020 £16,672\\ *European Community\\ *EURNETGEN - Shared costs project with representatives of 4 2000 - 2003 €1,300,000 Total other countries (coordinator). £239,743 Glasgow\\ *EURATools - European Rat Tools for Functional Genomics: 2006 - 2010 €3,900,000 Total multicentre award (coordinator Prof T Aitman). £377,334 Glasgow\\ *INGenious HyperCare - Integrating Genomics, Clinical Research & 2007 - 2011 €18,199,947 Total\\ *Care in Hypertension; multicentre award (coordinator Prof A Zanchetti) £896,785 Glasgow\\ *EURATrans - European large-scale functional genomics in the 2009 - 2014 €10,500,000 Total rate for translational research (coordinator Norbert Hübner). £303,499 Glasgow\\ *EU-MASCARA - MArkers for Subclinical CArdiovascular 2011 - 2015 €6,000,000 Total Risk Assessment (coordinator) £1,019,256 Glasgow\\ *EU-InterPregGen - Genetic studies of pre-eclampsia in Central 2011 - 2016 €5,000,000 Total \\ *Asian and European populations £178,984 \\ \\